Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Ozempic](/topic/ozempic)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:ozempic/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/ozempic/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +9%  
**6 Months**: XX% no change  
**1 Year**: XX% +5%  
**1-Year High**: XX% on 2025-05-12  
**1-Year Low**: X% on 2025-01-28  

**Most Supportive Themes**
- **Weight Loss Benefits and Positive Experiences:** (38%) Users are sharing positive experiences with Ozempic, highlighting its effectiveness in weight loss and improved health outcomes.
- **Novo Nordisk's Price Cuts:** (15%) Novo Nordisk is cutting the price of Ozempic for cash-paying patients, making it more accessible.
- **Canadian Approval for Kidney Disease:** (5%) Ozempic has been approved in Canada to reduce the risk of kidney failure and cardiovascular death in type X diabetes patients.
  
**Most Critical Themes**
- **Lawsuits and Side Effects:** (40%)  Numerous lawsuits are being filed against Novo Nordisk alleging severe side effects from Ozempic, including gastroparesis and vision loss.
- **Financial Setbacks and Competition:** (5%)  Novo Nordisk faces challenges, including a missed maintenance fee, competition from Eli Lilly, and a hiring freeze.
- **Concerns about Long-Term Effects:** (5%)  There are concerns about the long-term effects of Ozempic, including the potential for weight regain after stopping the medication.
  
Network engagement breakdown:  
| Network | Positive  | %   | Neutral | %   | Negative | %   |
| ------- | --------  | -   | ------- | -   | -------- | -   |
| News    | XXXXXXX   | X%  | XXXXX   | X%  | XXXXX    | X%  |
| Reddit  | XXXXX     | X%  | XXXXX   | X%  | XXX      | X%  |
| X       | XXXXXXX   | XX% | XXXXXX  | X%  | XXXXXXX  | XX% |
| TikTok  | XXXXXXX   | X%  | XXXXXXX | X%  | XXXXXXX  | X%  |
| YouTube | XXXXXXX   | X%  | XXXXXXX | XX% | XXXXXX   | X%  |
|         |           |     |         |     |          |     |
| Total   | XXXXXXXXX | XX% | XXXXXXX | XX% | XXXXXXX  | XX% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Ozempic

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +9%
6 Months: XX% no change
1 Year: XX% +5%
1-Year High: XX% on 2025-05-12
1-Year Low: X% on 2025-01-28

Most Supportive Themes

  • Weight Loss Benefits and Positive Experiences: (38%) Users are sharing positive experiences with Ozempic, highlighting its effectiveness in weight loss and improved health outcomes.
  • Novo Nordisk's Price Cuts: (15%) Novo Nordisk is cutting the price of Ozempic for cash-paying patients, making it more accessible.
  • Canadian Approval for Kidney Disease: (5%) Ozempic has been approved in Canada to reduce the risk of kidney failure and cardiovascular death in type X diabetes patients.

Most Critical Themes

  • Lawsuits and Side Effects: (40%) Numerous lawsuits are being filed against Novo Nordisk alleging severe side effects from Ozempic, including gastroparesis and vision loss.
  • Financial Setbacks and Competition: (5%) Novo Nordisk faces challenges, including a missed maintenance fee, competition from Eli Lilly, and a hiring freeze.
  • Concerns about Long-Term Effects: (5%) There are concerns about the long-term effects of Ozempic, including the potential for weight regain after stopping the medication.

Network engagement breakdown:

Network Positive % Neutral % Negative %
News XXXXXXX X% XXXXX X% XXXXX X%
Reddit XXXXX X% XXXXX X% XXX X%
X XXXXXXX XX% XXXXXX X% XXXXXXX XX%
TikTok XXXXXXX X% XXXXXXX X% XXXXXXX X%
YouTube XXXXXXX X% XXXXXXX XX% XXXXXX X%
Total XXXXXXXXX XX% XXXXXXX XX% XXXXXXX XX%
Ozempic Sentiment
/topic/ozempic/sentiment